{"version":"1.0","type":"link","title":"Efficacy and Safety of Different Dosages of Anlotinib Combined with PD-1 Monoclonal Antibody in the Treatment of Advanced Non-Small Cell Lung Cancer.","author_name":"Jiang J 외","author_url":"https://prs-insight.online/author/Jiang%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99341","thumbnail_width":1200,"thumbnail_height":630}